Key points are not available for this paper at this time.
We developed a novel promoter system, designated SR alpha, which is composed of the simian virus 40 (SV40) early promoter and the R segment and part of the U5 sequence (R-U5') of the long terminal repeat of human T-cell leukemia virus type 1. The R-U5' sequence stimulated chloramphenicol acetyltransferase (CAT) gene expression only when placed immediately downstream of the SV40 early promoter in the sense orientation. The SR alpha expression system was 1 or 2 orders of magnitude more active than the SV40 early promoter in a wide variety of cell types, including fibroblasts and lymphoid cells, and was capable of promoting a high level of expression of various lymphokine cDNAs. These features of the SR alpha promoter were incorporated into the pcD-cDNA expression cloning vector originally developed by Okayama and Berg.
Building similarity graph...
Analyzing shared references across papers
Loading...
Yutaka Takebe
University Malaya Medical Centre
Motoharu Seiki
Kanazawa University
Jun–ichi Fujisawa
Kansai Medical University
Molecular and Cellular Biology
The Cancer Institute Hospital
Cellular Research (United States)
Building similarity graph...
Analyzing shared references across papers
Loading...
Takebe et al. (Fri,) studied this question.
synapsesocial.com/papers/6a194f59427684435388e679 — DOI: https://doi.org/10.1128/mcb.8.1.466-472.1988
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: